A biochemical analysis of thoracic neuroblastomas: A pediatric oncology group study

Stephen J. Shochat, Nancy L. Corbelletta, Mary Ann Repman, Cara Lynne Schengrund

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A biochemical analysis was performed on tumor tissuesfrom 20 patients who presented with thoracic neuroblastomas. Nine patients were under 1 year of age at the time of diagnosis, and 12 patients had stage A disease. Eighteen of the 20 patients are disease free with a mean follow-up of 51/2 years. The ganglioside composition of the tumor tissue was investigated, since these cell membrane components have been proposed to play a role in cell to cell interaction and may be altered on cell transformation. In addition, the ganglioside composition of the central nervous system changes with maturation. Previous studies in children with neuroblastoma have shown that tumor tissue containing more complex gangliosides is associated with a better prognosis. Neuroblastomas from patients with thoracic primaries were found to contain more complex gangliosides of the b series (GD1b, GT1b) and fewer monosialogangliosides, suggesting a more differentiated cellular composition. Tissue from one of the thoracic patients who died lacked GT1b. The absence of this ganglioside has proven to be an indicator of a poor prognosis. Four specimens contained no detectable GD2, which is thought to be a specific marker for neuroblastomas. These data suggest that the improved prognosis seen with thoracic neuroblas-tomas is due to a basic biologic difference within these tumors, and this finding should be taken into consideration when planning therapy.

Original languageEnglish (US)
Pages (from-to)660-664
Number of pages5
JournalJournal of pediatric surgery
Volume22
Issue number7
DOIs
StatePublished - Jul 1987

Fingerprint

Neuroblastoma
Gangliosides
Thorax
Pediatrics
Neoplasms
Cellular Structures
Cell Communication
Central Nervous System
Cell Membrane

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Shochat, Stephen J. ; Corbelletta, Nancy L. ; Repman, Mary Ann ; Schengrund, Cara Lynne. / A biochemical analysis of thoracic neuroblastomas : A pediatric oncology group study. In: Journal of pediatric surgery. 1987 ; Vol. 22, No. 7. pp. 660-664.
@article{ddd2f126f81b47f7b3b98d2a960f5596,
title = "A biochemical analysis of thoracic neuroblastomas: A pediatric oncology group study",
abstract = "A biochemical analysis was performed on tumor tissuesfrom 20 patients who presented with thoracic neuroblastomas. Nine patients were under 1 year of age at the time of diagnosis, and 12 patients had stage A disease. Eighteen of the 20 patients are disease free with a mean follow-up of 51/2 years. The ganglioside composition of the tumor tissue was investigated, since these cell membrane components have been proposed to play a role in cell to cell interaction and may be altered on cell transformation. In addition, the ganglioside composition of the central nervous system changes with maturation. Previous studies in children with neuroblastoma have shown that tumor tissue containing more complex gangliosides is associated with a better prognosis. Neuroblastomas from patients with thoracic primaries were found to contain more complex gangliosides of the b series (GD1b, GT1b) and fewer monosialogangliosides, suggesting a more differentiated cellular composition. Tissue from one of the thoracic patients who died lacked GT1b. The absence of this ganglioside has proven to be an indicator of a poor prognosis. Four specimens contained no detectable GD2, which is thought to be a specific marker for neuroblastomas. These data suggest that the improved prognosis seen with thoracic neuroblas-tomas is due to a basic biologic difference within these tumors, and this finding should be taken into consideration when planning therapy.",
author = "Shochat, {Stephen J.} and Corbelletta, {Nancy L.} and Repman, {Mary Ann} and Schengrund, {Cara Lynne}",
year = "1987",
month = "7",
doi = "10.1016/S0022-3468(87)80122-7",
language = "English (US)",
volume = "22",
pages = "660--664",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "7",

}

A biochemical analysis of thoracic neuroblastomas : A pediatric oncology group study. / Shochat, Stephen J.; Corbelletta, Nancy L.; Repman, Mary Ann; Schengrund, Cara Lynne.

In: Journal of pediatric surgery, Vol. 22, No. 7, 07.1987, p. 660-664.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A biochemical analysis of thoracic neuroblastomas

T2 - A pediatric oncology group study

AU - Shochat, Stephen J.

AU - Corbelletta, Nancy L.

AU - Repman, Mary Ann

AU - Schengrund, Cara Lynne

PY - 1987/7

Y1 - 1987/7

N2 - A biochemical analysis was performed on tumor tissuesfrom 20 patients who presented with thoracic neuroblastomas. Nine patients were under 1 year of age at the time of diagnosis, and 12 patients had stage A disease. Eighteen of the 20 patients are disease free with a mean follow-up of 51/2 years. The ganglioside composition of the tumor tissue was investigated, since these cell membrane components have been proposed to play a role in cell to cell interaction and may be altered on cell transformation. In addition, the ganglioside composition of the central nervous system changes with maturation. Previous studies in children with neuroblastoma have shown that tumor tissue containing more complex gangliosides is associated with a better prognosis. Neuroblastomas from patients with thoracic primaries were found to contain more complex gangliosides of the b series (GD1b, GT1b) and fewer monosialogangliosides, suggesting a more differentiated cellular composition. Tissue from one of the thoracic patients who died lacked GT1b. The absence of this ganglioside has proven to be an indicator of a poor prognosis. Four specimens contained no detectable GD2, which is thought to be a specific marker for neuroblastomas. These data suggest that the improved prognosis seen with thoracic neuroblas-tomas is due to a basic biologic difference within these tumors, and this finding should be taken into consideration when planning therapy.

AB - A biochemical analysis was performed on tumor tissuesfrom 20 patients who presented with thoracic neuroblastomas. Nine patients were under 1 year of age at the time of diagnosis, and 12 patients had stage A disease. Eighteen of the 20 patients are disease free with a mean follow-up of 51/2 years. The ganglioside composition of the tumor tissue was investigated, since these cell membrane components have been proposed to play a role in cell to cell interaction and may be altered on cell transformation. In addition, the ganglioside composition of the central nervous system changes with maturation. Previous studies in children with neuroblastoma have shown that tumor tissue containing more complex gangliosides is associated with a better prognosis. Neuroblastomas from patients with thoracic primaries were found to contain more complex gangliosides of the b series (GD1b, GT1b) and fewer monosialogangliosides, suggesting a more differentiated cellular composition. Tissue from one of the thoracic patients who died lacked GT1b. The absence of this ganglioside has proven to be an indicator of a poor prognosis. Four specimens contained no detectable GD2, which is thought to be a specific marker for neuroblastomas. These data suggest that the improved prognosis seen with thoracic neuroblas-tomas is due to a basic biologic difference within these tumors, and this finding should be taken into consideration when planning therapy.

UR - http://www.scopus.com/inward/record.url?scp=0023278203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023278203&partnerID=8YFLogxK

U2 - 10.1016/S0022-3468(87)80122-7

DO - 10.1016/S0022-3468(87)80122-7

M3 - Article

C2 - 3612463

AN - SCOPUS:0023278203

VL - 22

SP - 660

EP - 664

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 7

ER -